Dries Cardoen

Dries Cardoen, Nelson Labs - Qepler Summits And Conferences

Dries Cardoen

Team Responsible of E&L Study Directors - Inhalation/Topical/Transdermal products
Nelson Labs
Leuven, Belgium
We are a leading, global testing lab specializing in expert advisory and testing solutions for medical device, pharmaceutical, tissue & biologics companies

Dries Cardoen received his Ph.D. from the Faculty of Biology at the University of Leuven (Belgium) in 2011.

After his academic career as a post-doctoral researcher, he started at Nelson Labs (formerly Toxikon Europe) in 2013 as study director in the Extractables & Leachables Department.

From the start, he specialized in E&L projects of inhalation drug products. He is currently leading the team of study directors that is specialized in E&L testing of inhalation drug products and topical and transdermal drug products.

Related Sessions:

Qepler - Extractables & Leachables Summit thumbnail Details

Extractables & Leachables
Summit 2019

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 15 Oct 2019
  • Berlin, DE
  • Pharma
Day 2: Wednesday, 16 October 2019
CASE STUDY: Errors in chromatographic screening
  • The risk of omission: omitting a compound in chromatographic screening is a fatal error, as the assessment of the extractables or leachables profile is irreversibly compromised by committing the error
  • The risk of inexact identification: if the wrong identity for a compound is secured, then clearly the substance’s impact on the devices suitability cannot be assessed as the link between the extractable and its relevant toxicological information cannot be established
  • The risk of inaccurate and imprecise quantitation in chromatographic screening processes
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.